FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894829079> ?p ?o ?g. }

• W2894829079 endingPage "227" @default.
• W2894829079 startingPage "218" @default.
• W2894829079 abstract "Latent tuberculosis infection (LTBI) is a critical driver of the global burden of active TB, and therefore LTBI treatment is key for TB elimination. Treatment regimens for LTBI include self-administered daily isoniazid for 6 (6H) or 9 (9H) months, self-administered daily rifampicin plus isoniazid for 3 months (3RH), self-administered daily rifampicin for 4 months (4R) and weekly rifapentine plus isoniazid for 3 months self-administered (3HP-SAT) or administered by a healthcare worker as directly observed therapy (3HP-DOT). Data on the relative cost-effectiveness of these regimens are needed to assist policymakers and clinicians in selecting an LTBI regimen.To evaluate the cost-effectiveness of all regimens for treating LTBI.We developed a Markov model to investigate the cost-effectiveness of 3HP-DOT, 3HP-SAT, 4R, 3RH, 9H and 6H for LTBI treatment in a cohort of 10000 adults with LTBI. Cost-effectiveness was evaluated from a health system perspective over a 20 year time horizon.Compared with no preventive treatment, 3HP-DOT, 3HP-SAT, 4R, 3RH, 9H and 6H prevented 496, 470, 442, 418, 370 and 276 additional cases of active TB per 10000 patients, respectively. All regimens reduced costs and increased QALYs compared with no preventive treatment. 3HP was more cost-effective under DOT than under SAT at a cost of US$27948 per QALY gained.Three months of weekly rifapentine plus isoniazid is more cost-effective than other regimens. Greater recognition of the benefits of short-course regimens can contribute to the scale-up of prevention and achieving the 'End TB' targets." @default.
• W2894829079 created "2018-10-12" @default.
• W2894829079 creator A5001775216 @default.
• W2894829079 creator A5021448672 @default.
• W2894829079 creator A5023179056 @default.
• W2894829079 creator A5030965705 @default.
• W2894829079 creator A5035852456 @default.
• W2894829079 creator A5051651214 @default.
• W2894829079 creator A5054786962 @default.
• W2894829079 creator A5057417364 @default.
• W2894829079 date "2018-10-05" @default.
• W2894829079 modified "2023-09-30" @default.
• W2894829079 title "Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study" @default.
• W2894829079 cites W1969018101 @default.
• W2894829079 cites W1980075079 @default.
• W2894829079 cites W1988576353 @default.
• W2894829079 cites W1994471959 @default.
• W2894829079 cites W2005128743 @default.
• W2894829079 cites W2043904209 @default.
• W2894829079 cites W2049687039 @default.
• W2894829079 cites W2056450991 @default.
• W2894829079 cites W2109182328 @default.
• W2894829079 cites W2110286623 @default.
• W2894829079 cites W2117419474 @default.
• W2894829079 cites W2117490789 @default.
• W2894829079 cites W2138041013 @default.
• W2894829079 cites W2138793372 @default.
• W2894829079 cites W2140909669 @default.
• W2894829079 cites W2148232746 @default.
• W2894829079 cites W2149791683 @default.
• W2894829079 cites W2165461110 @default.
• W2894829079 cites W2167461153 @default.
• W2894829079 cites W2167997312 @default.
• W2894829079 cites W2278425353 @default.
• W2894829079 cites W2334809297 @default.
• W2894829079 cites W2558345394 @default.
• W2894829079 cites W2588751641 @default.
• W2894829079 cites W2616479650 @default.
• W2894829079 cites W2766389926 @default.
• W2894829079 cites W2771796238 @default.
• W2894829079 cites W2778481507 @default.
• W2894829079 cites W2790610332 @default.
• W2894829079 cites W2795201395 @default.
• W2894829079 cites W2886632226 @default.
• W2894829079 doi "https://doi.org/10.1093/jac/dky403" @default.
• W2894829079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30295760" @default.
• W2894829079 hasPublicationYear "2018" @default.
• W2894829079 type Work @default.
• W2894829079 sameAs 2894829079 @default.
• W2894829079 citedByCount "26" @default.
• W2894829079 countsByYear W28948290792018 @default.
• W2894829079 countsByYear W28948290792019 @default.
• W2894829079 countsByYear W28948290792020 @default.
• W2894829079 countsByYear W28948290792021 @default.
• W2894829079 countsByYear W28948290792022 @default.
• W2894829079 countsByYear W28948290792023 @default.
• W2894829079 crossrefType "journal-article" @default.
• W2894829079 hasAuthorship W2894829079A5001775216 @default.
• W2894829079 hasAuthorship W2894829079A5021448672 @default.
• W2894829079 hasAuthorship W2894829079A5023179056 @default.
• W2894829079 hasAuthorship W2894829079A5030965705 @default.
• W2894829079 hasAuthorship W2894829079A5035852456 @default.
• W2894829079 hasAuthorship W2894829079A5051651214 @default.
• W2894829079 hasAuthorship W2894829079A5054786962 @default.
• W2894829079 hasAuthorship W2894829079A5057417364 @default.
• W2894829079 hasBestOaLocation W28948290791 @default.
• W2894829079 hasConcept C112930515 @default.
• W2894829079 hasConcept C126322002 @default.
• W2894829079 hasConcept C142724271 @default.
• W2894829079 hasConcept C2776688490 @default.
• W2894829079 hasConcept C2776967927 @default.
• W2894829079 hasConcept C2776991065 @default.
• W2894829079 hasConcept C2777975735 @default.
• W2894829079 hasConcept C2778607973 @default.
• W2894829079 hasConcept C2779806340 @default.
• W2894829079 hasConcept C2781069245 @default.
• W2894829079 hasConcept C2781413609 @default.
• W2894829079 hasConcept C3019080777 @default.
• W2894829079 hasConcept C515549039 @default.
• W2894829079 hasConcept C71924100 @default.
• W2894829079 hasConcept C72563966 @default.
• W2894829079 hasConceptScore W2894829079C112930515 @default.
• W2894829079 hasConceptScore W2894829079C126322002 @default.
• W2894829079 hasConceptScore W2894829079C142724271 @default.
• W2894829079 hasConceptScore W2894829079C2776688490 @default.
• W2894829079 hasConceptScore W2894829079C2776967927 @default.
• W2894829079 hasConceptScore W2894829079C2776991065 @default.
• W2894829079 hasConceptScore W2894829079C2777975735 @default.
• W2894829079 hasConceptScore W2894829079C2778607973 @default.
• W2894829079 hasConceptScore W2894829079C2779806340 @default.
• W2894829079 hasConceptScore W2894829079C2781069245 @default.
• W2894829079 hasConceptScore W2894829079C2781413609 @default.
• W2894829079 hasConceptScore W2894829079C3019080777 @default.
• W2894829079 hasConceptScore W2894829079C515549039 @default.
• W2894829079 hasConceptScore W2894829079C71924100 @default.
• W2894829079 hasConceptScore W2894829079C72563966 @default.
• W2894829079 hasIssue "1" @default.
• W2894829079 hasLocation W28948290791 @default.

• next